• Science & Technology
• Policy & Insight

What could DeepMind ‘solving’ the protein folding problem mean for cancer research?

We asked two of our protein specialists, who are trying to understand how the way proteins fold affect cancer outcomes, to give their verdict on the news. We asked two of our protein specialists, who are trying to understand how the way proteins fold affect cancer outcomes, to give their verdict on the news.

23 December 2020

• Health & Medicine

New treatment could spare early-stage rectal cancer patients life-altering side effects

A new and less invasive treatment developed by Cancer Research UK researchers is safer than standard major surgery for early-stage rectal cancer. A new and less invasive treatment developed by Cancer Research UK researchers is safer than standard major surgery for early-stage rectal cancer.

10 December 2020

• Charity News

Cancer Research UK forced to cut research funding due to COVID-19

Due to the effects of COVID-19, Cancer Research UK has had to cut its research funding by £45 million. Due to the effects of COVID-19, Cancer Research UK has had to cut its research funding by £45 million.

8 December 2020

• Science & Technology

The long road to targeting the holy grail of the immune response

A team of our scientists at University College London have developed a potential new immunotherapy drug and caused another paradigm shift in our understanding of how cancer immunotherapy works. A team of our scientists at University College London have developed a potential new immunotherapy drug and caused another paradigm shift in our understanding of how cancer immunotherapy works.

9 November 2020

• Health & Medicine
• Policy & Insight

Learning the lessons of COVID-19: Protecting cancer services and research through the pandemic

We're calling on UK governments to stand by their commitments to improving cancer survival and make sure everyone can receive the care they deserve. We're calling on UK governments to stand by their commitments to improving cancer survival and make sure everyone can receive the care they deserve.

9 November 2020

• Health & Medicine

Scientists develop next-generation immunotherapy now entering early phase clinical trials

Cancer Research UK scientists have invented a new experimental drug that aims to harness the full power of the body’s own immune system. Cancer Research UK scientists have invented a new experimental drug that aims to harness the full power of the body’s own immune system.

9 November 2020

• Health & Medicine

What's happened to cancer clinical trials during the COVID-19 pandemic?

As coronavirus cases continue to rise in the UK, we look at how cancer clinical trials have been affected by the pandemic. As coronavirus cases continue to rise in the UK, we look at how cancer clinical trials have been affected by the pandemic.

4 November 2020

• Science & Technology

We’re asking scientists to tackle 9 of the toughest challenges in cancer research

We’ve partnered with the National Cancer Institute in the US (NCI) to stimulate even more innovative research collaborations through Cancer Grand Challenges. We’ve partnered with the National Cancer Institute in the US (NCI) to stimulate even more innovative research collaborations through Cancer Grand Challenges.

14 October 2020

• Science & Technology
• Health & Medicine

Scientists develop new precision medicine approach for pancreatic cancer

Scientists from the University of Glasgow are developing new ways to predict who will respond to drugs targeting damaged DNA in pancreatic cancer.  Scientists from the University of Glasgow are developing new ways to predict who will respond to drugs targeting damaged DNA in pancreatic cancer. 

12 October 2020

• Health & Medicine

New drug targeting high-risk children’s cancer is ready for trials

A new drug that has passed safety tests in adults is likely to be effective against the aggressive childhood cancer neuroblastoma. A new drug that has passed safety tests in adults is likely to be effective against the aggressive childhood cancer neuroblastoma.

5 October 2020

• Health & Medicine

HPV vaccine reduces cervical cancer risk

Long awaited study results have confirmed that the quadrivalent human papillomavirus (HPV) vaccine substantially reduces invasive cervical cancer risk.   Long awaited study results have confirmed that the quadrivalent human papillomavirus (HPV) vaccine substantially reduces invasive cervical cancer risk.  

1 October 2020